Study detail
Recruiting
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
Brigham and Women's Hospital
Summary
This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.
Description
This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. In addition, we also examine blood and urine biomarkers (proteins).
Eligibility
- Age range
- 20–90 years
- Sex
- All
- Healthy volunteers
- No
Detailed criteria
Inclusion Criteria: * Undergoing heart surgery * Willing to provide consent Exclusion Criteria: * Enrolled in a concurrent drug or device trial that precludes concurrent enrollment
Locations (3)
- Brigham and Women's HospitalBoston, Massachusetts
- UT Southwestern Medical CenterDallas, Texas
- Department Texas Heart Institute at St. Luke's Episcopal HospitalHouston, Texas